36 participants
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2025-10-01
- Completion:
- 2028-03-15
Conditions
- Sjögren
- Sjogren Disease
- Sjogren's Syndrome
Interventions
- DRUG
No Results Yet